OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)	215
The advances of post-stroke depression: 2021 update	140
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex	127
Neurological and cognitive sequelae of Covid-19: a four month follow-up	107
Rituximab for the treatment of multiple sclerosis: a review	102
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study	90
Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials	89
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study	89
COVID-19 mRNA vaccination leading to CNS inflammation: a case series	78
Bell’s palsy following COVID-19 vaccination	71
Digital therapeutics in neurology	69
Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation	66
Association of CNS demyelination and COVID-19 infection: an updated systematic review	66
Ischemic stroke associated with COVID-19: a systematic review and meta-analysis	63
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients	62
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms	61
Burden of disease in myasthenia gravis: taking the patient’s perspective	60
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up	59
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine	58
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study	57
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review	56
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives	56
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung	56
Update on benign paroxysmal positional vertigo	55
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion	55

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential di	51
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19	51
Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature	50
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis	48
Neurological updates: neurological complications of CAR-T therapy	47
Alzheimer’s disease clinical trial update 2019–2021	46
Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis	45
Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis	45
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19	45
Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions	44
Telerehabilitation in response to constrained physical distance: an opportunity to rethink neurorehabilitative routines	43
Are some patient-perceived migraine triggers simply early manifestations of the attack?	42
Update cerebellum and cognition	42
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus	41
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses	41
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment	41